EUVIMEDEUVIMED entdecken
Crossref

Histoplasma antigens as novel players for the development of new enzyme immunoassays for the serodiagnosis of histoplasmosis: A comparative study of their analytical performance

Carolina Rodríguez Laboccetta, Víctor J Briceño Fernández, Agustín Videla Garrido, Gladys B Posse, María L Cuestas iD, Alejandro D Nusblat iD

Medical Mycology · 2024

DOI: 10.1093/mmy/myae023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2024. Verfasst von Carolina Rodríguez Laboccetta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Nanobiotecnología (NANOBIOTEC). Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Histoplasmosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: ANPCyT, CONICET, University of Buenos Aires.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Definitive diagnosis of histoplasmosis relies on culture and/or cytology/histopathology; however, these procedures have limited sensitivity and cultures are time-consuming. Antibodies detection by immunodiffusion has low sensitivity in immunocompromised individuals and uses histoplasmin (HMN), a crude antigenic extract, as reagent. Novel protein antigen candidates have been recently identified and produced by DNA-recombinant techniques to obtain standardized and specific reagents for diagnosing histoplasmosis. To compare the analytical performance of novel enzyme-linked immunosorbent assays (ELISAs) for antibodies testing for diagnosing histoplasmosis using different Histoplasma capsulatum antigens as reagents. The H. capsulatum 100 kDa protein (Hcp100), the M antigen and its immunoreactive fragment F1 were produced by DNA-recombinant techniques. Galactomannan was purified from both the yeast and mycelial cell walls (yGM and mGM, respectively). The analytical performance of the ELISA tests for the serological detection of antibodies against these antigens was evaluated and compared with those obtained using HMN as reagent. Antibodies detection by the Hcp100 ELISA demonstrated 90.0% sensitivity and 92.0% specificity, versus 43.3% sensitivity and 95.0% specificity of the M ELISA, 33.3% sensitivity and 84.0% specificity of the F1 ELISA, 96.7% sensitivity and 94.0% specificity of the yGM ELISA, 83.3% sensitivity and 88.0% specificity of the mGM ELISA, and 70.0% sensitivity and 86.0% specificity for the HMN ELISA. In summary, Hcp100 is proposed as the most promising candidate for the serodiagnosis of histoplasmosis. The primary immunoreactive element in HMN proved to be GM rather than the M antigen. Nevertheless, a higher incidence of cross-reactions was noted with GM compared to M.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistoplasmosisHumansHistoplasmaAntibodies, FungalImmunoenzyme TechniquesAntigens, FungalAntibodiesImmunodiffusionSaccharomyces cerevisiaeDNA

Stichwörter der Autor:innen

Histoplasma capsulatumELISAF1GMHMNHcp100Mantibodies detectiondiagnosis

Substanzen

Antibodies, FungalAntigens, FungalAntibodiesDNA

Autor:innen und Institutionen

  • Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Nanobiotecnología (NANOBIOTEC). Buenos Aires, Argentina.
  • Universidad de Buenos Aires. CONICET. Instituto de Investigaciones en Microbiología y Parasitología Médica (IMPaM). Buenos Aires, Argentina.
  • Laboratorio de Micología. Hospital Nacional Profesor Alejandro Posadas. Buenos Aires, Argentina.

ORCID-Profile: María L Cuestas, Alejandro D Nusblat

Förderung

  • ANPCyT
  • CONICET
  • University of Buenos Aires

Zitieren

APA

Rodríguez Laboccetta, C., Briceño Fernández, V. J., Videla Garrido, A., Posse, G. B., Cuestas, M. L., & Nusblat, A. D. (2024). Histoplasma antigens as novel players for the development of new enzyme immunoassays for the serodiagnosis of histoplasmosis: A comparative study of their analytical performance. Medical Mycology. https://doi.org/10.1093/mmy/myae023

Vancouver

Rodríguez Laboccetta C, Briceño Fernández VJ, Videla Garrido A, Posse GB, Cuestas ML, Nusblat AD. Histoplasma antigens as novel players for the development of new enzyme immunoassays for the serodiagnosis of histoplasmosis: A comparative study of their analytical performance. Medical Mycology. 2024. doi:10.1093/mmy/myae023

BibTeX
@article{RodrguezLaboccetta2024,
  author = {Rodríguez Laboccetta, Carolina and Briceño Fernández, Víctor J and Videla Garrido, Agustín and Posse, Gladys B and Cuestas, María L and Nusblat, Alejandro D},
  title = {Histoplasma antigens as novel players for the development of new enzyme immunoassays for the serodiagnosis of histoplasmosis: A comparative study of their analytical performance},
  journal = {Medical Mycology},
  year = {2024},
  doi = {10.1093/mmy/myae023}
}
Kostenlos starten →